Eugene Oliveto
Psychiatry · Bellevue, NENPI 1811061203
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 138 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 28.0% of the total. Reporting peaked in 2022 at $706 and has fallen 62.8% since, to $263 in 2023.
Across 138 payments — averaging $15.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$606
- Otsuka America Pharmaceutical, Inc.$323
- Takeda Pharmaceuticals U.S.A., Inc.$166
- Lundbeck LLC$134
- Novo Nordisk$115
- Avanir Pharmaceuticals, Inc.$92
- plus $728 from 22 others
What the payments were for
- Food & beverage$2,12798%
- Education$362%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$2,163 in reported general payments places this provider in the 80th percentile of 160 psychiatry providers in Nebraska.
Other psychiatry in Bellevue
- Angelo ZienoBellevue$1K
- Vithyalakshmi SelvarajOmaha$1.2M
- Sarit HovavOmaha$307K
- Mary Jo HaniganOmaha$119K
- Yon ChongOmaha$59K
- Navdeep SoodGrand Island$51K
- Walter DuffyLincoln$46K
- Dianna ClyneLincoln$19K
- Jeffrey CoffmanLincoln$18K
- Syed SattarOmaha$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.